Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

Dr. Shinohara on the Future of Radiation and Surgery in Prostate Cancer

Eric Shinohara, MD, MSCI
Published: Friday, Jan 24, 2020



Eric Shinohara, MD, MSCI, associate professor and interim chair, Vanderbilt University Medical Center, discusses the future of stereotactic body radiation (SBRT) and surgery in prostate cancer.

For men with limited metastatic disease, radiation therapy can be given beyond the prostate to treat other sites of disease.

However, the role of radiation or surgery may shift according to emerging data exploring these modalities in combination with immunotherapy, explains Shinohara.

Going forward, radiation and surgery may become more widely used for men with a low volume of metastatic disease, concludes Shinohara.
SELECTED
LANGUAGE


Eric Shinohara, MD, MSCI, associate professor and interim chair, Vanderbilt University Medical Center, discusses the future of stereotactic body radiation (SBRT) and surgery in prostate cancer.

For men with limited metastatic disease, radiation therapy can be given beyond the prostate to treat other sites of disease.

However, the role of radiation or surgery may shift according to emerging data exploring these modalities in combination with immunotherapy, explains Shinohara.

Going forward, radiation and surgery may become more widely used for men with a low volume of metastatic disease, concludes Shinohara.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x